Abstract | BACKGROUND: METHODS: A bioinformatics approach (ie, the BIMAS algorithm, National Institutes of Health, http://bimas.dcrt.nih.gov/molbio/hla_bind) was used to identify multiple immunogenic peptides derived from TADG-12 that bind to human leukocyte antigen-A2.1 and elicit peptide-specific human cytotoxic T lymphocyte (CTL) responses in healthy individuals and in patients with advanced stage ovarian cancer. RESULTS: CONCLUSIONS:
|
Authors | Stefania Bellone, Simone Anfossi, Timothy J O'Brien, Martin J Cannon, Dan-Arin Silasi, Masoud Azodi, Peter E Schwartz, Thomas J Rutherford, Sergio Pecorelli, Alessandro D Santin |
Journal | Cancer
(Cancer)
Vol. 115
Issue 4
Pg. 800-11
(Feb 15 2009)
ISSN: 0008-543X [Print] United States |
PMID | 19117353
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Copyright | (c) 2008 American Cancer Society. |
Chemical References |
- Antibodies, Monoclonal
- Cytokines
- HLA-A2 Antigen
- Peptide Fragments
- Serine Endopeptidases
- TADG-12 serine protease
|
Topics |
- Aged
- Antibodies, Monoclonal
(pharmacology)
- Antigen Presentation
- CD8-Positive T-Lymphocytes
(cytology, immunology)
- Cell Line
- Cystadenocarcinoma, Serous
(immunology, pathology)
- Cytokines
(metabolism)
- Dendritic Cells
(cytology, immunology)
- Female
- Flow Cytometry
- HLA-A2 Antigen
(immunology)
- Humans
- Middle Aged
- Ovarian Neoplasms
(immunology, pathology)
- Ovary
(cytology, immunology)
- Peptide Fragments
(immunology, metabolism)
- Serine Endopeptidases
(genetics, immunology)
- T-Lymphocytes, Cytotoxic
(immunology)
|